Literature DB >> 20686015

Simian immunodeficiency virus-specific CD8+ T cells recognize Vpr- and Rev-derived epitopes early after infection.

Jonah B Sacha1, Matthew B Buechler, Laura P Newman, Jason Reed, Lyle T Wallace, John T Loffredo, Nancy A Wilson, David I Watkins.   

Abstract

The kinetics of CD8(+) T cell epitope presentation contribute to the antiviral efficacy of these cells yet remain poorly defined. Here, we demonstrate presentation of virion-derived Vpr peptide epitopes early after viral penetration and prior to presentation of Vif-derived epitopes, which required de novo Vif synthesis. Two Rev epitopes exhibited differential presentation kinetics, with one Rev epitope presented within 1 h of infection. We also demonstrate that cytolytic activity mirrors the recognition kinetics of infected cells. These studies show for the first time that Vpr- and Rev-specific CD8(+) T cells recognize and kill simian immunodeficiency virus (SIV)-infected CD4(+) T cells early after SIV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686015      PMCID: PMC2950557          DOI: 10.1128/JVI.01357-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.

Authors:  Michael S Bennett; Hwee L Ng; Mirabelle Dagarag; Ayub Ali; Otto O Yang
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

2.  Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein.

Authors:  Jonah B Sacha; Matthew R Reynolds; Matthew B Buechler; Chungwon Chung; Anna K Jonas; Lyle T Wallace; Andrea M Weiler; Wonhee Lee; Shari M Piaskowski; Taeko Soma; Thomas C Friedrich; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

3.  Effective simian immunodeficiency virus-specific CD8+ T cells lack an easily detectable, shared characteristic.

Authors:  Lara Vojnov; Jason S Reed; Kim L Weisgrau; Eva G Rakasz; John T Loffredo; Shari M Piaskowski; Jonah B Sacha; Holly L Kolar; Nancy A Wilson; R Paul Johnson; David I Watkins
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

4.  Novel translation products from simian immunodeficiency virus SIVmac239 Env-encoding mRNA contain both Rev and cryptic T-cell epitopes.

Authors:  Nicholas J Maness; Jonah B Sacha; Shari M Piaskowski; Kimberly L Weisgrau; Eva G Rakasz; Gemma E May; Matthew B Buechler; Andrew D Walsh; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

5.  Robust, vaccine-induced CD8(+) T lymphocyte response against an out-of-frame epitope.

Authors:  Nicholas J Maness; Nancy A Wilson; Jason S Reed; Shari M Piaskowski; Jonah B Sacha; Andrew D Walsh; Elizabeth Thoryk; Gwendolyn J Heidecker; Michael P Citron; Xiaoping Liang; Andrew J Bett; Danilo R Casimiro; David I Watkins
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

6.  Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.

Authors:  John T Loffredo; John Sidney; Alex T Bean; Dominic R Beal; Wilfried Bardet; Angela Wahl; Oriana E Hawkins; Shari Piaskowski; Nancy A Wilson; William H Hildebrand; David I Watkins; Alessandro Sette
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

7.  Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge.

Authors:  Nancy A Wilson; Brandon F Keele; Jason S Reed; Shari M Piaskowski; Caitlin E MacNair; Andrew J Bett; Xiaoping Liang; Fubao Wang; Elizabeth Thoryk; Gwendolyn J Heidecker; Michael P Citron; Lingyi Huang; Jing Lin; Salvatore Vitelli; Chanook D Ahn; Masahiko Kaizu; Nicholas J Maness; Matthew R Reynolds; Thomas C Friedrich; John T Loffredo; Eva G Rakasz; Stephen Erickson; David B Allison; Michael Piatak; Jeffrey D Lifson; John W Shiver; Danilo R Casimiro; George M Shaw; Beatrice H Hahn; David I Watkins
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

8.  Candidate vaccine sequences to represent intra- and inter-clade HIV-1 variation.

Authors:  Otto O Yang
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

9.  HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms.

Authors:  Laurent Houzet; Jean Christophe Paillart; Fatima Smagulova; Stephan Maurel; Zakia Morichaud; Roland Marquet; Marylène Mougel
Journal:  Nucleic Acids Res       Date:  2007-04-10       Impact factor: 16.971

10.  AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape.

Authors:  Nicholas J Maness; Laura E Valentine; Gemma E May; Jason Reed; Shari M Piaskowski; Taeko Soma; Jessica Furlott; Eva G Rakasz; Thomas C Friedrich; David A Price; Emma Gostick; Austin L Hughes; John Sidney; Alessandro Sette; Nancy A Wilson; David I Watkins
Journal:  J Exp Med       Date:  2007-10-22       Impact factor: 14.307

View more
  16 in total

1.  Magnetic nanoparticles enhance adenovirus transduction in vitro and in vivo.

Authors:  Cédric Sapet; Christophe Pellegrino; Nicolas Laurent; Flavie Sicard; Olivier Zelphati
Journal:  Pharm Res       Date:  2011-12-07       Impact factor: 4.200

2.  Impaired immune evasion in HIV through intracellular delays and multiple infection of cells.

Authors:  Christian L Althaus; Rob J De Boer
Journal:  Proc Biol Sci       Date:  2012-04-04       Impact factor: 5.349

3.  Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.

Authors:  Diana Y Chen; Arumugam Balamurugan; Hwee L Ng; William G Cumberland; Otto O Yang
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

4.  Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.

Authors:  Szu-Han Huang; Yanqin Ren; Allison S Thomas; Dora Chan; Stefanie Mueller; Adam R Ward; Shabnum Patel; Catherine M Bollard; Conrad Russell Cruz; Sara Karandish; Ronald Truong; Amanda B Macedo; Alberto Bosque; Colin Kovacs; Erika Benko; Alicja Piechocka-Trocha; Hing Wong; Emily Jeng; Douglas F Nixon; Ya-Chi Ho; Robert F Siliciano; Bruce D Walker; R Brad Jones
Journal:  J Clin Invest       Date:  2018-01-22       Impact factor: 14.808

5.  Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.

Authors:  Iris Castro; Teresa M Giret; Diogo M Magnani; Helen S Maxwell; Oliver Umland; Jessica K Perry; Jerilyn K Pecotte; Kathleen M Brasky; Glen N Barber; Ronald C Desrosiers; David I Watkins
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

Review 6.  CD8(+)T-cell-mediated control of HIV-1 and SIV infection.

Authors:  Stephanie A Freel; Kevin O Saunders; Georgia D Tomaras
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

7.  Antiviral activity of human immunodeficiency virus type 1 Gag-specific cytotoxic T lymphocyte targeting is not necessarily intrinsically superior to envelope targeting.

Authors:  Diana Y Chen; Arumugam Balamurugan; Hwee L Ng; Otto O Yang
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

Review 8.  Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.

Authors:  Christian Plank; Olivier Zelphati; Olga Mykhaylyk
Journal:  Adv Drug Deliv Rev       Date:  2011-08-26       Impact factor: 15.470

9.  Enhanced Recognition of HIV-1 Cryptic Epitopes Restricted by HLA Class I Alleles Associated With a Favorable Clinical Outcome.

Authors:  Anju Bansal; Tiffanie Mann; Sarah Sterrett; Binghao J Peng; Anne Bet; Jonathan M Carlson; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

10.  Dynamics of Simian Immunodeficiency Virus Two-Long-Terminal-Repeat Circles in the Presence and Absence of CD8+ Cells.

Authors:  Benjamin B Policicchio; Erwing Fabian Cardozo; Paola Sette; Cuiling Xu; George Haret-Richter; Tammy Dunsmore; Cristian Apetrei; Ivona Pandrea; Ruy M Ribeiro
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.